Vimal Mehta, CEO, President and Secretary at BioXcel Therapeutics, Inc. (BTAI), bought 82,000 shares at $11.00 ($4.9M) on 2018-03-12, disclosed to the SEC on 2021-02-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.00 | 2,000 | $22K | 0.5% |
| 2 | $60.76 | 80,000 | $4.9M | 99.5% |
| Total | $59.55 avg | 82,000 | $4.9M | 100% |
| Filing → |
| BTAI | SELL | 2024-09-17 | $1K | — | Filing → |
| BTAI | SELL | 2024-06-18 | $3K | — | Filing → |
| BTAI | SELL | 2024-04-08 | $14K | — | Filing → |